Weighted Average Number of Shares Outstanding, Basic of Tevogen Bio Holdings Inc. from 30 Sep 2021 to 30 Sep 2025

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Tevogen Bio Holdings Inc. quarterly and annual Weighted Average Number of Shares Outstanding, Basic in shares history and change rate from 30 Sep 2021 to 30 Sep 2025.
  • Tevogen Bio Holdings Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending 30 Sep 2025 was 196,028,784, a 15% increase year-over-year.
  • Tevogen Bio Holdings Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2024 was 146,672,534, a 493% increase from 2023.
Source SEC data
View on sec.gov
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Change (%)

Tevogen Bio Holdings Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 196,028,784 +25,854,251 +15% 01 Jul 2025 30 Sep 2025 10-Q 14 Nov 2025 2025 Q3
Q2 2025 184,307,169 +30,140,079 +20% 01 Apr 2025 30 Jun 2025 10-Q 14 Aug 2025 2025 Q2
Q1 2025 161,407,123 +24,073,321 +18% 01 Jan 2025 31 Mar 2025 10-Q 14 May 2025 2025 Q1
Q4 2024 146,672,534 +121,920,534 +493% 01 Oct 2024 31 Dec 2024 10-K 02 Apr 2025 2024 FY
Q3 2024 170,174,533 +50,174,544 +42% 01 Jul 2024 30 Sep 2024 10-Q 14 Nov 2025 2025 Q3
Q2 2024 154,167,090 +34,167,101 +28% 01 Apr 2024 30 Jun 2024 10-Q 14 Aug 2025 2025 Q2
Q1 2024 137,333,802 +17,333,813 +14% 01 Jan 2024 31 Mar 2024 10-Q 14 May 2025 2025 Q1
Q4 2023 24,752,000 01 Oct 2023 31 Dec 2023 10-K 02 Apr 2025 2024 FY
Q3 2023 119,999,989 01 Jul 2023 30 Sep 2023 10-Q 19 Nov 2024 2024 Q3
Q2 2023 119,999,989 01 Apr 2023 30 Jun 2023 10-Q 14 Aug 2024 2024 Q2
Q1 2023 119,999,989 01 Jan 2023 31 Mar 2023 10-Q 28 May 2024 2024 Q1
Q3 2021 10,320,290 01 Jul 2021 30 Sep 2021 10-Q 17 Dec 2021 2021 Q3

Tevogen Bio Holdings Inc. Annual Weighted Average Number of Shares Outstanding, Basic (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 146,672,534 +121,920,534 +493% 01 Jan 2024 31 Dec 2024 10-K 02 Apr 2025 2024 FY
2023 24,752,000 01 Jan 2023 31 Dec 2023 10-K 02 Apr 2025 2024 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.